- A Eurozone SRI/ESG selection fund with a combination of themes
The SRI equity fund Edmond de Rothschild Euro Sustainable Growth is a combination of ESG screening and multi thematic approach. It seeks to pick stocks with interesting growth prospects which also strive to apply best sustainable development principles. The investable universe is defined through the selection of stocks with minimum ESG rating of A combined with a selection of growth stocks that operate principally on market segments that are typically exposed to sustainability issues: energy transition, healthcare and population, digitalisation, education & research…
From this investable universe, we conduct financial and stock market analysis and construct a portfolio of around 40-50 positions. The fund's managers-analysts also regularly monitor indicators on the portfolio's extra-financial impact. Thus, the fund currently focuses on different indicators as carbon emissions (carbon footprint/intensity/exposition), “green impact”, rate of staff absenteeism or injury frequency, proportion of women on executive committee and whether companies are signatories to the UN's Global Compact. These indicators help track the fund's extra-financial performance compared to its benchmark index: they have been disclosed in a new document available in French version on our website and entitled “Performance Extra-Financière : l’exemple d’Edmond de Rothschild Euro Sustainable Growth”. The contents of this document also includes the fund’s voting activity.
Edmond de Rothschild Euro Sustainable Growth received the new French SRI label after an audit of its process and transparency by EY in September 2017.
- A global thematic fund focused on the Health sector
Edmond de Rothschild Asset Management (France) also manages a socially thematic equity fund on healthcare :Edmond de Rothschild Fund Healthcare*. This fund invests at least 60% of its net assets in securities issued by companies operating the healthcare sector (biotechnology, pharmaceuticals, medical technology, medical diagnosis, hospital and healthcare centre management, and other medical services) as well as companies marketing these products or services. *a sub fund of the Luxembourg-regulated SICAV which is approved by the CSSF, managed by Edmond de Rothschild Asset Management (Luxembourg) and for which Edmond de Rothschild Asset Management (France) is the sub investment manager